Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Rang in aandelen #178
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Aandeelprijs
$44.60
Marktkapitalisatie
$108.62B
Verandering (1 dag)
-1.63%
Verandering (1 jaar)
-21.62%
Land
FR
Handel Sanofi (SNY)

Categorie

Winst voor Sanofi (SNY)
Winst in Dec 2025 TTM: $7.06B
Volgens de meest recente financiële verslagen van Sanofi bedraagt de huidige winst van het bedrijf $7.06B. In 2024 behaalde het bedrijf een winst van $7.03B, een stijging ten opzichte van de winst van 2023, die $6.76B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Sanofi van 2000 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $7.06B 0.00%
2025 $7.06B 0.44%
2024 $7.03B 4.03%
2023 $6.76B -36.93%
2022 $10.72B 20.27%
2021 $8.91B -48.24%
2020 $17.22B 410.31%
2019 $3.37B -40.13%
2018 $5.64B -16.37%
2017 $6.74B 10.21%
2016 $6.11B 7.85%
2015 $5.67B -16.42%
2014 $6.78B 9.05%
2013 $6.22B -23.52%
2012 $8.13B -0.71%
2011 $8.19B -14.33%
2010 $9.56B -3.08%
2009 $9.87B 45.83%
2008 $6.76B -25.57%
2007 $9.09B 43.73%
2006 $6.32B 95.83%
2005 $3.23B -3.31%
2004 $3.34B -15.22%
2003 $3.94B 49.74%
2002 $2.63B 21.90%
2001 $2.16B 43.20%
2000 $1.51B 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$25.73B 264.29%
US
$12.40B 75.59%
GB
$32.58B 361.29%
US
$6.60B -6.60%
US
$16.35B 131.51%
CH